Dr. M. (Myriam) Neumann

Researcher
Pharmaceutics
m.neumann@uu.nl

[1]        M. Neumann et al., “Stimuli-Responsive Hydrogels: The Dynamic Smart Biomaterials of Tomorrow,” Macromolecules, vol. 56, no. 21, pp. 8377–8392, 2023, doi: 10.1021/acs.macromol.3c00967.

[2]  M. Neumann, C. Rolin, M. Claux, T. Arnould, and B.-L. Su, “Design and Synthesis of Biocompatible Alginate-SiO 2 -TiO 2 Capsules with Tunable Porosity for Immune-isolation in Mammalian Cell Encapsulation,” Submitted in J. Tissue Eng. Regen. Med., 2024.

[3]        L. Wang, M. Neumann, T. Fu, W. Li, X. Cheng, and B. L. Su, “Porous and responsive hydrogels for cell therapy,” Curr. Opin. Colloid Interface Sci., vol. 38, pp. 135–157, 2018, doi: 10.1016/j.cocis.2018.10.010.

[4]        G. Leroux et al., “Hybrid Alginate@TiO 2 Porous Microcapsules as a Reservoir of Animal Cells for Cell Therapy,” ACS Appl. Mater. Interfaces, vol. 10, no. 44, pp. 37865–37877, 2018, doi: 10.1021/acsami.8b15483.

[5]        G. Leroux, M. Neumann, C. F. Meunier, C. Michiels, L. Wang, and B. L. Su, “Alginate@TiO2 hybrid microcapsules as a reservoir of beta INS-1E cells with controlled insulin delivery,” J. Mater. Sci., vol. 55, no. 18, pp. 7857–7869, 2020, doi: 10.1007/s10853-020-04576-9.

[6]        C. Casadidio et al., “Effect of Polyplex Size on Penetration into Tumor Spheroids,” Mol. Pharm., vol. 20, no. 11, pp. 5515–5531, 2023, doi: 10.1021/acs.molpharmaceut.3c00397.